SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-18
👔
CLOVER HEALTH INVESTMENTS, CORP. /DE
@CLOV_InsiderForm 4 Filing: Reynoso Jamie L. Sells $11,280.8 of $CLOV
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
CLOVER HEALTH INVESTMENTS, CORP. /DE
Ticker: $CLOV
Transaction Value
$11,280.8
Price/Share: $4.78
transaction date
2026-06-17
Shares: 2,360
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Reynoso Jamie L., holds the title of CEO, Medicare Advantage at CLOVER HEALTH INVESTMENTS, CORP. /DE.
On 2026-06-17, the insider transacted 2,360 shares.The shares were transacted at a weighted average price of $4.78 per share, resulting in a total market-relevant value of $11,280.8.
Executive Summary Summary
Reynoso Jamie L. (CEO, Medicare Advantage) sold $11K of $CLOV
Post-Transaction Position: 2,841,211 shares
SEC Accession No: 0001839066-26-000024 (CIK: 1839066)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.